SNUS
Shares of Sonus Pharmaceuticals Inc (SNUS.O: Quote, Profile, Research) crashed more than 83 percent after the company said a late-stage trial of its lead experimental drug for metastatic breast cancer failed to meet its main goal.
Shares of Sonus Pharmaceuticals Inc (SNUS.O: Quote, Profile, Research) crashed more than 83 percent after the company said a late-stage trial of its lead experimental drug for metastatic breast cancer failed to meet its main goal.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
